The company was founded by two individuals with expertise in AI, data science, image analysis, and machine learning who wanted to contribute to human well-being. Their Galen™ platform uses AI to detect cancer as accurately as a human pathologist, eliminating diagnostic errors, implementing real-time quality control, reducing diagnosis time, and boosting productivity. The platform has been deployed worldwide and is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs. The company's multidisciplinary team of entrepreneurs, data scientists, software engineers, and medical experts is passionate about transforming cancer diagnosis with AI and improving patient care.